Editorial introduction
Old friends, new ways: revisiting extended lymphadenectomy and neoadjuvant chemotherapy to improve outcomes
New molecular markers for bladder cancer detection
Fluorescence cystoscopy and bladder surveillance
Second-line intravesical therapy versus cystectomy for bacille Calmette-Guérin (BCG) failures
Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?)
Novel therapeutics in the treatment of bladder cancer
Integrating basic science and clinical research in bladder cancer: update from the first bladder Specialized Program of Research Excellence (SPORE)
Current World Literature